“…Following their establishment in the CNS, microglia are highly mobile and primarily use an amoeboid morphology to regulate neural circuits (Nayak, Roth, & McGavern, 2014) F I G U R E 3 Alteration of microglial properties and molecular signaling in neurodevelopmental disorders. Microglial alterations, such as morphological abnormalities, altered microglial density and cell number (Morgan et al, 2010), high levels of inflammatory cytokines (Vargas, Nascimbene, Krishnan, Zimmerman, & Pardo, 2005) and glutamate (Maezawa & Jin, 2010), compromised phagocytosis (Sekar et al, 2016), excess synapses, and altered connectivity (Filipello et al, 2018;Sellgren et al, 2019), have been shown to occur in neurodevelopmental disorders. Moreover, molecular alterations, such as upregulation of SHANK proteins and Psd95 in neurons (Kim et al, 2017), altered TREM2 expression (Edmonson, Ziats, & Rennert, 2014;Filipello et al, 2018), and elevated levels of CX3CR1 and BDNF in microglia have been associated with ASD (Edmonson et al, 2014;Ricci et al, 2013).…”